PPIDT00204
Drug Information
| Name | Siplizumab |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB06371 |
| Type | biotech |
| Indication | Investigated for use/treatment in psoriasis and psoriatic disorders, transplant (rejection), graft versus host disease, lymphoma (unspecified), and leukemia (unspecified). |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| No dosage records. | ||